Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about James Lanthier
Recent news which mentions James Lanthier
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
October 07, 2022
Tickers
MSSTF
Tags
Market News
Markets
Cannabis
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
Psychedelics
Cybin
Market News
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
Clinical Trial Authorization
Markets
Guidance
From
Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
September 07, 2022
Tickers
MSSTF
Tags
MSP/1014
James Lanthier
Benzinga
From
Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
August 31, 2022
Tickers
MSSTF
Tags
MSSTF
News
Management
From
Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
June 30, 2022
Tickers
MSSTF
Tags
News
MSSTF
Drug Discovery
From
Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
June 22, 2022
Tickers
MSSTF
Tags
Markets
WHO
MSSTF
From
Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
June 10, 2022
Tickers
MSSTF
Tags
the United States Patent and Trademark Office
News
MSSTF
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.